circulating anticoagulant activity that had at least two distinct mechanisms -- one directed against factor xii and one directed against blood thromboplastin ( prothrombin activator complex ) -- developed in a patient with clinical and laboratory evidence of procainamide hydrochloride-induced systemic lupus erythematosus .
C0600311
procainamide hydrochloride
C0024141
systemic